𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Alterations of p53, cyclin D1, rb, and H-ras in human oral carcinomas related to tobacco use

✍ Scribed by Jie Xu; Irma B. Gimenez-Conti; Joan E. Cunningham; Ana M. Collet; Mario A. Luna; Hector E. Lanfranchi; Margaret R. Spitz; Claudio J. Conti


Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
445 KB
Volume
83
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis


BACKGROUND.

Epidemiologic studies have indicated that environmental and personal habits, particularly tobacco use and alcohol abuse, are major etiologic factors in the induction and progression of head and neck squamous cell carcinomas (HNSCC). Molecular studies have focused on HNSCC related to smoking but not those associated with smokeless tobacco.

METHODS.

The authors studied immunohistochemical evidence of alterations of p53, cyclin D1, and Rb in 34 human oral carcinomas related to tobacco use. They also examined p53 and H-ras using single strand conformation polymorphism (SSCP) and sequencing analysis.

RESULTS.

Overexpression of cyclin D1 was found in 41% of cases, and accumulation of p53 was found in 59%. Only 9% of the samples did not show Rb staining. In SSCP and sequencing analysis, 17 cases showed mutations in the conserved region of the p53 gene. No mutations were detected in codons 12, 13, or 61 of the H-ras gene.

CONCLUSIONS.

Overexpression of cyclin D1 and p53 mutations are common alterations in HNSCC. In contrast, the loss of Rb function seems to occur infrequently, and mutations in the H-ras gene apparently do not play a role in this cancer.

HNSCC associated with smokeless tobacco contained the same alterations as those related to smoking.


πŸ“œ SIMILAR VOLUMES


TP53 alterations in relation to the cell
✍ Skomedal, Hanne; Kristensen, Gunnar B.; Nesland, Jahn M.; BοΏ½rresen-Dale, Anne-Li πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 283 KB πŸ‘ 2 views

In the present study, TP53 alterations have been analysed and compared with the expression of the proteins p21, cyclin D1, cdk4, RB, EGFR, and MDM2 in 53 cancers of the uterine corpus. TP53 gene mutations analysed by CDGE/DGGE and direct sequencing showed a TP53 gene mutation in 18 per cent of the c